RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Cash and cash equivalents

GILEAD SCIENCES, INC.GILD

Market cap
$155.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 20249,991+64.19%
Dec 31, 20236,085+12.44%
Dec 31, 20225,412+1.39%
Dec 31, 20215,338-10.99%
Dec 31, 20205,997-48.44%
Dec 31, 201911,631-35.17%
Dec 31, 201817,940+136.43%
Dec 31, 20177,588-7.79%
Dec 31, 20168,229-35.97%
Dec 31, 201512,851+28.16%
Dec 31, 201410,027+374.58%
Dec 31, 20132,113+17.14%
Dec 31, 20121,804-81.75%
Dec 31, 20119,884+988.67%
Dec 31, 2010908

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)